Edward O’Brien

Edward O’Brien

Company: Seres Therapeutics

Job title: Senior Scientist - Microbiome Sciences

Seminars:

Panel Discussion: Using AI-Enhanced Phenotyping to Provide Novel Understanding of IBD Heterogeneity 9:30 am

To what extent will AI reshape the classification of IBD subtypes? What insights does classify IBD subtypes provide into disease heterogeneity? Delving into AI-enhanced phenotyping for tailoring bespoke treatment options Read more

day: AI/Machine Learning Pre-Conference Focus Day

Biomarkers of microbiome disruption for patient stratification in clinical trials of microbiome therapeutics in IBD 4:30 pm

Microbiome heterogeneity in structural, functional, and immuno-modulatory properties in IBD Baseline biomarkers predictive of microbiome therapeutic pharmacodynamics in IBD Relating microbiome disruption and immuno-modulatory properties to inform patient stratificationRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.